Meredith Gunlicks-Stoessel

Meredith Gunlicks-Stoessel

Auto-generated profile, based on publicly available information

Meredith Gunlicks-Stoessel

Department of Psychiatry & Behavioral Sciences, University of Minnesota – Twin Cities, Minneapolis, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
MGMeredith L. Gunlicks
Meredith L. Gunlicks
MWMyrna M. Weissman
Myrna M. Weissman

1 April 2006 in Journal of Personality and Social Psychology
Verified
Journal Article
Closed access
SPSally I. Powers
Sally I. Powers
PPPaula R. Pietromonaco
Paula R. Pietromonaco
MGMeredith Gunlicks
Meredith Gunlicks
ASAline Sayer
Aline Sayer
This study investigated theoretically predicted links between attachment style and a physiological indicator of stress, salivary cortisol levels, in 124 heterosexual dating couples. Cortisol was assessed at 7 points before and after an experimental conflict negotiation task, creating a trajectory of stress reactivity and recovery for each participant. Growth modeling of cortisol data tested hypotheses that (a) insecurely attached individuals show patterns of greater physiological stress reactions to interpersonal conflict than do securely attached individuals and (b) people with insecurely attached partners show patterns of greater stress in reaction to relationship conflict than those with securely attached partners. Hypothesis 1 was supported, but men and women differed in the type of insecure attachment that predicted stress trajectories. Hypothesis 2 was supported for men, but not for women. The discussion emphasizes the role of gender role norms and partner characteristics in understanding connections between adult attachment and patterns of cortisol responses to interpersonal stress.

22 March 2012 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
DADaniel Almirall
Daniel Almirall
SCScott N. Compton
Scott N. Compton
MGMeredith Gunlicks‐Stoessel
Meredith Gunlicks‐Stoessel
NDNaihua Duan
Naihua Duan
SMSusan A. Murphy
Susan A. Murphy

1 September 2018 in Journal of Child and Adolescent Psychopharmacology
Verified
Journal Article
Closed access
KCKathryn R. Cullen
Kathryn R. Cullen
PAPalistha Amatya
Palistha Amatya
MRMark G. Roback
Mark G. Roback
CAChristina Sophia Albott
Christina Sophia Albott
MSMelinda Westlund Schreiner
Melinda Westlund Schreiner
BKBonnie Klimes-Dougan
Bonnie Klimes-Dougan
Background: Novel interventions for treatment-resistant depression (TRD) in adolescents are urgently needed. Ketamine has been studied in adults with TRD, but little information is available for adolescents. This study investigated efficacy and tolerability of intravenous ketamine in adolescents with TRD, and explored clinical response predictors. Methods: Adolescents, 12–18 years of age, with TRD (failure to respond to two previous antidepressant trials) were administered six ketamine (0.5 mg/kg) infusions over 2 weeks. Clinical response was defined as a 50% decrease in Children's Depression Rating Scale-Revised (CDRS-R); remission was CDRS-R score ≤28. Tolerability assessment included monitoring vital signs and dissociative symptoms using the Clinician-Administered Dissociative States Scale (CADSS). Results: Thirteen participants (mean age 16.9 years, range 14.5–18.8 years, eight biologically male) completed the protocol. Average decrease in CDRS-R was 42.5% (p = 0.0004). Five (38%) adolescents met criteria for clinical response. Three responders showed sustained remission at 6-week follow-up; relapse occurred within 2 weeks for the other two responders. Ketamine infusions were generally well tolerated; dissociative symptoms and hemodynamic symptoms were transient. Higher dose was a significant predictor of treatment response. Conclusions: These results demonstrate the potential role for ketamine in treating adolescents with TRD. Limitations include the open-label design and small sample; future research addressing these issues are needed to confirm these results. Additionally, evidence suggested a dose–response relationship; future studies are needed to optimize dose. Finally, questions remain regarding the long-term safety of ketamine as a depression treatment; more information is needed before broader clinical use.

1 January 2010 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
MGMeredith Gunlicks-Stoessel
Meredith Gunlicks-Stoessel
LMLaura Mufson
Laura Mufson
AJAngela Jekal
Angela Jekal
JTJ. Blake Turner
J. Blake Turner
Aspects of depressed adolescents' perceived interpersonal functioning were examined as moderators of response to treatment among adolescents treated with interpersonal psychotherapy for depressed adolescents (IPT-A; Mufson, Dorta, Moreau, & Weissman, 2004) or treatment as usual (TAU) in school-based health clinics. Sixty-three adolescents (12-18 years of age) participated in a clinical trial examining the effectiveness of IPT-A (Mufson, Dorta, Wickramaratne, et al., 2004). The sample was 84.1% female and 15.9% male (mean age = 14.67 years). Adolescents were 74.6% Latino, 14.3% African American, 1.6% Asian American, and 9.5% other. They came primarily from low-income families. Adolescents were randomly assigned to receive IPT-A or TAU delivered by school-based mental health clinicians. Assessments, completed at baseline and at Weeks 4, 8, and 12 (or at early termination), included the Hamilton Rating Scale for Depression (Hamilton, 1967), the Conflict Behavior Questionnaire (Robin & Foster, 1989), and the Social Adjustment Scale-Self-Report (Weissman & Bothwell, 1976). Multilevel modeling indicated that treatment condition interacted with adolescents' baseline reports of conflict with their mothers and social dysfunction with friends to predict the trajectory of adolescents' depressive symptoms over the course of treatment, controlling for baseline levels of depression. The benefits of IPT-A over TAU were particularly strong for the adolescents who reported high levels of conflict with their mothers and social dysfunction with friends. Replication with larger samples would suggest that IPT-A may be particularly helpful for depressed adolescents who are reporting high levels of conflict with their mothers or interpersonal difficulties with friends.

18 March 2015 in Journal of Clinical Child & Adolescent Psychology
Verified
Journal Article
Closed access
MGMeredith Gunlicks-Stoessel
Meredith Gunlicks-Stoessel
LMLaura Mufson
Laura Mufson
AWAna Westervelt
Ana Westervelt
DADaniel Almirall
Daniel Almirall
SMSusan Murphy
Susan Murphy
This pilot study was conducted to assess the feasibility and acceptability of 4 adaptive treatment strategies (ATSs) for adolescent depression to plan for a subsequent full-scale clinical trial. The ATSs aim to address 2 questions that arise when personalizing treatment: (a) For adolescents treated with Interpersonal Psychotherapy for depressed adolescents (IPT-A; Mufson et al., 2004 Mufson, L. , Dorta, K. P. , Moreau, D. , & Weissman, M. M. (2004). Interpersonal psychotherapy for depressed adolescents (2nd ed.). New York, NY: Guilford Press. [Google Scholar] ), at what time point should therapists make the determination that the adolescent is not likely to respond if the initial treatment plan is continued (week 4 or week 8)? (b) For adolescents who are judged to need their treatment augmented, should the therapist increase the number of IPT-A sessions or add pharmacotherapy (fluoxetine)? A 16-week pilot sequential multiple assignment randomized trial (SMART) was conducted with 32 adolescents (M age = 14.9) who had a diagnosis of major depressive disorder, dysthymic disorder, or depressive disorder not otherwise specified. Adolescents were primarily female (75%) and Caucasian (84.4%). Data regarding the feasibility and acceptability of the study and treatment procedures and treatment response rates were collected. Week 4 was the more feasible and acceptable decision point for assessing need for a change to treatment. Adolescents, parents, and therapists reported a range of attitudes about medication and more intensive therapy as treatment options. Results from the pilot study have yielded additional research questions for the full-scale SMART and will improve our ability to successfully conduct the trial.